Medicalsystem Biotechnology Co., Ltd.
SZSE:300439.SZ
11.11 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | |||||||||||||
Net Income
| 256.551 | 205.204 | 190.153 | 293.568 | -576.627 | 252.959 | 225.092 | 188.101 | 159.462 | 136.79 | 103.259 | 91.735 | 54.454 |
Depreciation & Amortization
| 169.631 | 191.672 | 194.821 | 173.52 | 161.484 | 150.325 | 109.111 | 67.552 | 42.441 | 30.528 | 19.571 | 11.781 | 6.166 |
Deferred Income Tax
| 0 | -10.246 | -8.607 | 39.511 | -11.604 | 16.187 | -7.584 | -6.689 | -2.619 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 10.547 | 4.846 | 0 | 0 | 0 | 0 | 0 |
Change In Working Capital
| 165.206 | 71.612 | 18.598 | 496.002 | 83.472 | -109.634 | -527.723 | -257.481 | -39.413 | -63.461 | -33.196 | -66.009 | -12.147 |
Accounts Receivables
| 206.658 | -76.756 | -147.176 | 372.345 | 125.27 | -265.508 | -579.226 | -177.678 | -33.245 | -48.202 | -48.897 | -58.782 | 0 |
Inventory
| -58.017 | -20.712 | 15.311 | 81.769 | -44.559 | 53.863 | -109.246 | -136.234 | -37.252 | -24.863 | -6.01 | -25.44 | -10.432 |
Accounts Payables
| 34.976 | 179.326 | 159.071 | 2.376 | 14.365 | 85.825 | 156.541 | 63.12 | 33.703 | 0 | 0 | 0 | 0 |
Other Working Capital
| -18.411 | -10.246 | -8.607 | 39.511 | -11.604 | -163.497 | -418.478 | -121.246 | -2.161 | -38.598 | -27.186 | -40.569 | -1.715 |
Other Non Cash Items
| 71.701 | 96.177 | 111.91 | -51.014 | 932.842 | 125.153 | 65.124 | 4.282 | 15.059 | 12.653 | 10.43 | 9.271 | 1.352 |
Operating Cash Flow
| 663.089 | 564.665 | 515.482 | 912.075 | 601.171 | 418.803 | -128.397 | 2.454 | 177.548 | 116.511 | 100.064 | 46.778 | 49.825 |
Investing Activities: | |||||||||||||
Investments In Property Plant And Equipment
| -280.369 | -303.134 | -201.816 | -383.435 | -363.203 | -446.218 | -412.19 | -292.59 | -92.275 | -73.635 | -72.609 | -56.603 | -30.713 |
Acquisitions Net
| 77.963 | 33.545 | 5.204 | 13.415 | 17.018 | -172.386 | 0.33 | -117.103 | -21.739 | 12.037 | 0 | 0 | -28.126 |
Purchases Of Investments
| -272.7 | -280.4 | -300.6 | 26.463 | -164.6 | -843.311 | -1,067.956 | -1,369.062 | -468.62 | -111.958 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 321.063 | 308.661 | 276.613 | 74.233 | 185.859 | 1,015.298 | 1,045.488 | 1,068.071 | 184.708 | 70.524 | 0 | 0 | 0 |
Other Investing Activites
| -46.737 | 8.836 | 33.04 | 16.305 | 36.373 | -4.523 | 41.382 | -7.19 | -9.015 | 11.658 | 0.603 | 0.195 | -4.25 |
Investing Cash Flow
| -200.781 | -232.492 | -187.56 | -253.02 | -288.552 | -451.139 | -392.946 | -717.874 | -406.941 | -91.373 | -72.006 | -56.408 | -63.089 |
Financing Activities: | |||||||||||||
Debt Repayment
| -228.039 | -149.241 | -476.619 | -575.286 | 1.572 | 267.69 | 556.19 | 360 | -100.77 | 22.77 | 11 | 37 | 1.5 |
Common Stock Issued
| 0 | 0 | 0 | -0.9 | 13.459 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock Repurchased
| 0 | 0 | 0 | -27.877 | -13.459 | -6.138 | -17.107 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| -49.881 | -36.385 | -60.025 | -125.375 | -50.214 | -116.398 | -49.231 | -45.326 | -2.55 | -35.775 | -4.476 | -3.809 | -3.513 |
Other Financing Activities
| -16.462 | -21.125 | 592.208 | -44.824 | -150.239 | -78.486 | 156.68 | 157.804 | 715.727 | -1.2 | 0.688 | -0.74 | 35.125 |
Financing Cash Flow
| -294.382 | -221.075 | 24.201 | -774.263 | -290.754 | 66.669 | 652.899 | 472.478 | 612.408 | -14.205 | 7.212 | 32.451 | 33.112 |
Other Information: | |||||||||||||
Effect Of Forex Changes On Cash
| 0.545 | -1.583 | 0.934 | -0.099 | -0.798 | 2.342 | -4.098 | 3.807 | 1.054 | 0.016 | -0 | -0 | 0 |
Net Change In Cash
| 168.471 | 109.516 | 353.058 | -115.307 | 21.066 | 36.675 | 127.459 | -239.135 | 384.07 | 10.949 | 35.269 | 22.822 | 19.848 |
Cash At End Of Period
| 958.882 | 783.853 | 674.336 | 321.279 | 436.585 | 415.519 | 376.286 | 248.827 | 487.962 | 103.893 | 92.944 | 57.674 | 34.852 |